Targeting stroma and tumor, silencing galectin 1 treats orthotopic mouse hepatocellular carcinoma.
Journal Information
Full Title: Acta Pharm Sin B
Abbreviation: Acta Pharm Sin B
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Pharmacology & Pharmacy
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Conflicts of interest The authors declare no potential competing interests."
"The authors thank the Genomics Shared Resource (GSR) core facility at the University of California, Davis Health, Dr. Clifford G Tepper, Stephanie Liu, Ryan Davis, for helping in performing spatial RNA sequencing, and William Amato for his assistance in the quantification of immunohistochemistry slides. This manuscript is supported by grants funded by the USA National Institutes of Health (NIH) T32 CA108459–15, R01CA222490, R50CA243787. BioRender was used to draw mice figures in schematic experimental design. Conceptualization, methodology, and study design: Yu-Jui Yvonne Wan and Tahereh Setayesh; Resources: Ying Hu, Farzam Vaziri, Tahereh Setayesh, Yu-Jui Yvonne Wan; Data acquisition, data analysis, and interpretation: Tahereh Setayesh, Farzam Vaziri, Ying Hu, Xin Chen, Jinping Lai, and Dongguang Wei; Writing - Original Draft: Tahereh Setayesh, Yu-Jui Yvonne Wan; Review & Editing: All authors; Visualization: Yu-Jui Yvonne Wan and Tahereh Setayesh; Funding acquisition: Yu-Jui Yvonne Wan and Tahereh Setayesh, Ying Hu."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025